Zenith Epigenetics
Calgary
About Zenith Epigenetics
Zenith Epigenetics is a research and development biotechnology company focused on new and innovative drugs by leveraging its proprietary epigenetics platform. The company's epigenetic drug discovery platform functions by inhibiting BET bromodomains, having the potential to impact multiple diseases including autoimmune and oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $16.6M
- Last round: Series Unknown (May 2015)
- Website: zenithepigenetics.com
- Phone: (403) 254-9252
Industries & Categories
Biotechnology, Health Care, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/zenith-epigenetics-2432086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.